General Information of the Compound
Compound ID
CP0877292
Compound Name
grandisine D
    Show/Hide
Synonyms
(+)-Grandisine D
Grandisine D
grandisine D
    Show/Hide
Structure
Formula
C16H21NO2
Molecular Weight
259.349
Canonical SMILES
C[C@H]1CC=CC(=O)[C@@H]1C(=O)C1=CCCN2CCC[C@@H]12
    Show/Hide
InChI
InChI=1S/C16H21NO2/c1-11-5-2-8-14(18)15(11)16(19)12-6-3-9-17-10-4-7-13(12)17/h2,6,8,11,13,15H,3-5,7,9-10H2,1H3/t11-,13-,15+/m0/s1
    Show/Hide
InChIKey
FKYCJVGMJYUVIJ-CORIIIEPSA-N
Physicochemical Property
logP
2.1313
Rotatable Bonds
2
Heavy Atom Count
19
Polar Areas
37.38
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16040172
SID: 24422937
ChEMBL ID
CHEMBL612043
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 1650 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Grandisine D )
Drug Name Grandisine D
Target(s)
Opioid receptor delta (OPRD1)
Inhibitor